These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 32706068

  • 1. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D, Wang J, Ma LJ, Yang HB, Jing JF, Jia MM, Zhang XJ, Guo F, Gao JN.
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [Abstract] [Full Text] [Related]

  • 2. miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.
    Wang M, Zhang H, Yang F, Qiu R, Zhao X, Gong Z, Yu W, Zhou B, Shen B, Zhu W.
    J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
    [Abstract] [Full Text] [Related]

  • 3. Plasma-based microRNA signatures in early diagnosis of breast cancer.
    Li X, Zou W, Wang Y, Liao Z, Li L, Zhai Y, Zhang L, Gu S, Zhao X.
    Mol Genet Genomic Med; 2020 May; 8(5):e1092. PubMed ID: 32124558
    [Abstract] [Full Text] [Related]

  • 4. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
    Zhang N, Zhang PP, Huang JJ, Wang ZY, Zhang ZH, Yuan JZ, Ma EM, Liu X, Bai J.
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL, Chen YL, Ge ZZ, Qu YY, Cao Y, Kang ZX.
    Cancer Biomark; 2019 Jan; 26(1):69-77. PubMed ID: 31306108
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
    Li W, Ding X, Wang S, Xu L, Yin T, Han S, Geng J, Sun W.
    J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
    [Abstract] [Full Text] [Related]

  • 7. Detection significance of miR-3662, miR-146a, and miR-1290 in serum exosomes of breast cancer patients.
    Li S, Zhang M, Xu F, Wang Y, Leng D.
    J Cancer Res Ther; 2021 Jul; 17(3):749-755. PubMed ID: 34269309
    [Abstract] [Full Text] [Related]

  • 8. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
    Zhang W, Su X, Li S, Liu Z, Wang Q, Zeng H.
    Cancer Biomark; 2020 Jul; 27(4):485-491. PubMed ID: 32065786
    [Abstract] [Full Text] [Related]

  • 9. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
    Zhang Z, Zhang L, Yu G, Sun Z, Wang T, Tian X, Duan X, Zhang C.
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
    [Abstract] [Full Text] [Related]

  • 10. Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer.
    Wang X, Qian T, Bao S, Zhao H, Chen H, Xing Z, Li Y, Zhang M, Meng X, Wang C, Wang J, Gao H, Liu J, Zhou M, Wang X.
    Mol Oncol; 2021 Sep; 15(9):2466-2479. PubMed ID: 34058065
    [Abstract] [Full Text] [Related]

  • 11. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F, Ying H, He B, Pan Y, Sun H, Wang S.
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [Abstract] [Full Text] [Related]

  • 12. Circulating serum exosomal miR-92a-3p as a novel biomarker for early diagnosis of gastric cancer.
    Lu X, Lu J, Wang S, Zhang Y, Ding Y, Shen X, Jing R, Ju S, Chen H, Cong H.
    Future Oncol; 2021 Mar; 17(8):907-919. PubMed ID: 33533649
    [Abstract] [Full Text] [Related]

  • 13. Serum Exosomal miR-17-5p as a Promising Biomarker Diagnostic Biomarker for Breast Cancer.
    Lv S, Wang Y, Xu W, Dong X.
    Clin Lab; 2020 Sep 01; 66(9):. PubMed ID: 32902214
    [Abstract] [Full Text] [Related]

  • 14. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y, Xu H.
    J Clin Lab Anal; 2020 Jun 01; 34(6):e23237. PubMed ID: 32061007
    [Abstract] [Full Text] [Related]

  • 15. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma.
    Que R, Ding G, Chen J, Cao L.
    World J Surg Oncol; 2013 Sep 04; 11():219. PubMed ID: 24007214
    [Abstract] [Full Text] [Related]

  • 16. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
    Qiu ML, Li X, Lin JB, Luo RG, Liu B, Feng Z.
    Eur Rev Med Pharmacol Sci; 2020 May 04; 24(10):5412-5418. PubMed ID: 32495876
    [Abstract] [Full Text] [Related]

  • 17. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M, Zhou Y, Xia T, Zhou X, Huang Z, Zhang H, Zhu W, Ding Q, Wang S.
    Breast Cancer Res Treat; 2018 Jul 04; 170(2):257-270. PubMed ID: 29557526
    [Abstract] [Full Text] [Related]

  • 18. The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart Healthcare.
    Deng P, Li M, Wu Y.
    J Healthc Eng; 2022 Jul 04; 2022():5914541. PubMed ID: 35028121
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic Value of Exosomal miR-148a-3p in the Serum of Patients with Differentiated Thyroid Cancer.
    Li S, Zhang S, Yang W, Li F, Long H.
    Clin Lab; 2021 Feb 01; 67(2):. PubMed ID: 33616326
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
    Liu W, Liu J, Zhang Q, Wei L.
    Cancer Biomark; 2020 Feb 01; 27(1):113-120. PubMed ID: 31771047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.